Trial Profile
Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2023
Price :
$35
*
At a glance
- Drugs Bupropion (Primary) ; Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 27 Mar 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to completed.
- 07 Mar 2012 New trial record